PLA2G2A and cardiomyopathy: Furthermore, genetic studies in mice demonstrated phospholipase Pla2g2a to promote myocardial injury in response to ischemia and oxidative damage [66], and we selected Sycp2 for its increased expression in cardiomyopathy [67].